Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.
Newspoint on MSN
Spirometry test: Check your lung capacity amid toxic air
As winter descends and major urban centers—most notably Delhi-NCR and northern India—choke under suffocating layers of toxic ...
Affinity Technologies Inc (NASDAQ:BIAF) recorded 235 CyPath Lung tests in October, the highest monthly volume for its ...
President and CEO Maria Zannes spoke with Proactive's Stephen Gunnion about record testing volumes for the company's CyPath Lung test, growing physician adoption and plans to expand its commercial ...
What are pulmonary function tests? Pulmonary function tests (PFTs) are tests of lung function. They are intended to evaluate and monitor chronic obstructive pulmonary disease (COPD). COPD is ...
Lung volume reduction surgery (LVRS) is a treatment for end-stage lung disease caused by emphysema. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath ...
Removing race from equations that estimate lung function will shift the categorization of disease severity across patient populations, moving more Black individuals into an advanced disease category, ...
Among patients with a very early diagnosis of systemic sclerosis (VEDOSS), a baseline diffusing capacity of the lungs for carbon monoxide by single breath (DLCO/SB) below 70% was associated with a ...
A meta-analysis of fourteen studies indicates that pulmonary rehabilitation significantly enhances exercise capacity and lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results